Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

The integration of TuneLab into Schrodinger’s cloud-based LiveDesign platform will provide biotech companies with direct ...

Schrödinger (SDGR) stock is in focus as the firm teams up with Eli Lilly (LLY) to integrate its LiveDesign software with ...

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...

Simulations Plus Q1 fiscal 2026 EPS miss as software revenue fall 17%, but services momentum and strong bookings support ...

MobileAppDaily improves vendor discovery through its directories, offering enterprises a more streamlined, transparent ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, synthesize, and optimize small molecules for multiple undisclosed targets.

The platform outlines its evaluation-first approach as enterprises demand clearer standards in how technology vendors are ...

Let's look at the pros and cons of going full AI to help you understand how the value and purpose of software development ...

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today ...